INHIBITORS OF CYCLO-OXYGENASE

被引：0
|
作者：
DEGAETANO, G [1 ]
CERLETTI, C [1 ]
DEJANA, E [1 ]
机构：
[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
来源：
EUROPEAN HEART JOURNAL | 1983年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [31] Allergenic sensitization prevents upregulation of haemopoiesis by cyclo-oxygenase inhibitors in mice
    Lintomen, L
    Elsas, MICG
    Maximiano, ES
    Neto, HAD
    Joseph, D
    Vargaftig, BB
    Elsas, PX
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (05) : 1315 - 1323
  • [32] Is elevated cardiovascular risk a class effect of cyclo-oxygenase 2 inhibitors?
    Solomon, Scott D.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (10): : 532 - 533
  • [33] Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?
    Chan, AT
    Fuchs, CS
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (09): : 434 - 435
  • [34] Non aspirin NSAIDs, cyclo-oxygenase 2 inhibitors and the risk for stroke
    Roumie, C. L.
    Mitchel, E.
    Kallenbach, L.
    Arbogast, P.
    Gideon, P.
    Griffin, M. R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 53 - 53
  • [35] Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates
    Allegaert, K
    Vanhole, C
    de Hoon, J
    Guignard, JP
    Tibboel, D
    Devlieger, H
    Van Overmeire, B
    PEDIATRIC NEPHROLOGY, 2005, 20 (11) : 1557 - 1561
  • [36] Cyclo-oxygenase inhibitors in adjunctive therapy of ulcerative bacterial keratitis.
    Gomez, A
    Hernandez, A
    Climent, A
    Munoz, S
    Ramirez, T
    Grane, E
    Alanis, L
    Almanzar, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 1422 - 1422
  • [37] Cyclo-oxygenase 2 inhibitors, NSAIDs, and the risk of cardiovascular events - Commentary
    Solomon, Daniel H.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (11): : 586 - 587
  • [38] Cyclo-oxygenase inhibitors and pancreatic enzymes synergistically cause cholangiopathy.
    LloydStill, J
    Beno, D
    Uhing, M
    Kimura, R
    HEPATOLOGY, 1997, 26 (04) : 1071 - 1071
  • [39] CYCLO-OXYGENASE INHIBITORS AND CELL KILLING BY CYTO-TOXIC DRUGS
    BENNETT, A
    GAFFEN, JD
    CHAMBERS, E
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 : 427 - 430
  • [40] Is elevated cardiovascular risk a class effect of cyclo-oxygenase 2 inhibitors?
    Scott D Solomon
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 532 - 533
12345